4TIM - Header Asymmetric Unit

HEADER ISOMERASE(INTRAMOLECULAR OXIDOREDUCTASE)11-APR-91 4TIM

TITLE CRYSTALLOGRAPHIC AND MOLECULAR MODELING STUDIES ON TITLE 2 TRYPANOSOMAL TRIOSEPHOSPHATE ISOMERASE: A CRITICAL TITLE 3 ASSESSMENT OF THE PREDICTED AND OBSERVED STRUCTURES OF THE TITLE 4 COMPLEX WITH 2-PHOSPHOGLYCERATE

COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRIOSEPHOSPHATE ISOMERASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 5.3.1.1; COMPND 5 ENGINEERED: YES

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TRYPANOSOMA BRUCEI BRUCEI; SOURCE 3 ORGANISM_TAXID: 5702; SOURCE 4 STRAIN: BRUCEI

KEYWDS ISOMERASE(INTRAMOLECULAR OXIDOREDUCTASE)

EXPDTA X-RAY DIFFRACTION

AUTHOR M.E.M.NOBEL,R.K.WIERENGA,W.G.J.HOL

REVDAT 3 24-FEB-09 4TIM 1 VERSN REVDAT 2 01-APR-03 4TIM 1 JRNL REVDAT 1 15-OCT-92 4TIM 0

JRNL AUTH M.E.NOBLE,C.L.VERLINDE,H.GROENDIJK,K.H.KALK, JRNL AUTH 2 R.K.WIERENGA,W.G.HOL JRNL TITL CRYSTALLOGRAPHIC AND MOLECULAR MODELING STUDIES ON JRNL TITL 2 TRYPANOSOMAL TRIOSEPHOSPHATE ISOMERASE: A CRITICAL JRNL TITL 3 ASSESSMENT OF THE PREDICTED AND OBSERVED JRNL TITL 4 STRUCTURES OF THE COMPLEX WITH 2-PHOSPHOGLYCERATE. JRNL REF J.MED.CHEM. V. 34 2709 1991 JRNL REFN ISSN 0022-2623 JRNL PMID 1895291 JRNL DOI 10.1021/JM00113A007

REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.E.M.NOBLE,R.K.WIERENGA,A.-M.LAMBEIR, REMARK 1 AUTH 2 F.R.OPPERDOES,A.-M.W.H.THUNNISSEN,K.H.KALK, REMARK 1 AUTH 3 H.GROENDIJK,W.G.J.HOL REMARK 1 TITL THE ADAPTABILITY OF THE ACTIVE SITE OF REMARK 1 TITL 2 TRYPANOSOMAL TRIOSEPHOSPHATE ISOMERASE AS OBSERVED REMARK 1 TITL 3 IN THE CRYSTAL STRUCTURES OF THREE DIFFERENT REMARK 1 TITL 4 COMPLEXES REMARK 1 REF PROTEINS V. 10 50 1991 REMARK 1 REFN ISSN 0887-3585 REMARK 1 REFERENCE 2 REMARK 1 AUTH R.K.WIERENGA,M.E.M.NOBLE,J.P.M.POSTMA,H.GROENDIJK, REMARK 1 AUTH 2 K.H.KALK,W.G.J.HOL,F.R.OPPERDOES REMARK 1 TITL THE CRYSTAL STRUCTURE OF THE "OPEN" AND THE REMARK 1 TITL 2 "CLOSED" CONFORMATION OF THE FLEXIBLE LOOP OF REMARK 1 TITL 3 TRYPANOSOMAL TRIOSEPHOSPHATE ISOMERASE REMARK 1 REF PROTEINS V. 10 33 1991 REMARK 1 REFN ISSN 0887-3585 REMARK 1 REFERENCE 3 REMARK 1 AUTH R.K.WIERENGA,M.E.M.NOBLE,G.VRIEND,S.NAUCHE, REMARK 1 AUTH 2 W.G.J.HOL REMARK 1 TITL REFINED 1.83 ANGSTROMS STRUCTURE OF TRYPANOSOMAL REMARK 1 TITL 2 TRIOSEPHOSPHATE ISOMERASE, CRYSTALLIZED IN THE REMARK 1 TITL 3 PRESENCE OF 2.4 M-AMMONIUM SULPHATE. A COMPARISON REMARK 1 TITL 4 WITH THE STRUCTURE OF THE TRYPANOSOMAL REMARK 1 TITL 5 TRIOSEPHOSPHATE ISOMERASE-GLYCEROL-3-PHOSPHATE REMARK 1 TITL 6 COMPLEX REMARK 1 REF J.MOL.BIOL. V. 220 995 1991 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 4 REMARK 1 AUTH R.K.WIERENGA,K.H.KALK,W.G.J.HOL REMARK 1 TITL STRUCTURE DETERMINATION OF THE GLYCOSOMAL REMARK 1 TITL 2 TRIOSEPHOSPHATE ISOMERASE FROM TRYPANOSOMA BRUCEI REMARK 1 TITL 3 BRUCEI AT 2.4 ANGSTROMS RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 198 109 1987 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 5 REMARK 1 AUTH R.K.WIERENGA,W.G.J.HOL,O.MISSET,F.R.OPPERDOES REMARK 1 TITL PRELIMINARY CRYSTALLOGRAPHIC STUDIES OF REMARK 1 TITL 2 TRIOSEPHOSPHATE ISOMERASE FROM THE BLOOD PARASITE REMARK 1 TITL 3 TRYPANOSOMA BRUCEI BRUCEI REMARK 1 REF J.MOL.BIOL. V. 178 487 1984 REMARK 1 REFN ISSN 0022-2836

REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 17456 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.149 REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3766 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 11 REMARK 3 SOLVENT ATOMS : 130 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.013 ; NULL ; NULL REMARK 3 BOND ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES (A) : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS (A) : NULL ; NULL ; NULL REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : NULL REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL

REMARK 4 REMARK 4 4TIM COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.

REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL

REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.31 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.38 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: THE CRYSTALS USED FOR THIS REMARK 280 STRUCTURE DETERMINATION WERE GROWN IN THE PRESENCE OF 2.4M REMARK 280 AMMONIUM SULFATE (SEE PROTEIN DATA BANK ENTRIES 2TIM AND 5TIM) REMARK 280 , BUT BEFORE DATA COLLECTION THESE CRYSTALS WERE TRANSFERRED REMARK 280 TO A MOTHER LIQUOR WITHOUT SULFATE CONTAINING 30MM 2- REMARK 280 PHOSPHOGLYCERATE. THE ACTIVE SITE OF CHAIN *A* ("OPEN"- REMARK 280 CONFORMATION) HAS NO BOUND 2-PHOSPHOGLYCERATE. THE ACTIVE SITE REMARK 280 OF CHAIN *B* ("CLOSED"-CONFORMATION) HAS A BOUND 2- REMARK 280 PHOSPHOGLYCERATE.

REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 56.29500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 23.35000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.64500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 23.35000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 56.29500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 48.64500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL

REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: REMARK 300 THE ASYMMETRIC UNIT CONSISTS OF A DIMER. THE TWO MOLECULES REMARK 300 HAVE BEEN ASSIGNED CHAIN INDICATORS *A* AND *B*.

REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3460 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18860 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -25.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000

REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 SECONDARY STRUCTURE SPECIFICATIONS WERE MADE BY USE OF REMARK 400 PROGRAM *DSSP* OF W. KABSCH AND C. SANDER.

REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 MET B 1

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE2 GLU A 205 NH2 ARG A 220 2564 1.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 53 CD GLU A 53 OE2 0.074 REMARK 500 GLU A 97 CD GLU A 97 OE2 0.069 REMARK 500 GLU A 104 CD GLU A 104 OE2 0.094 REMARK 500 GLU A 107 CD GLU A 107 OE2 0.066 REMARK 500 GLU A 129 CD GLU A 129 OE2 0.082 REMARK 500 GLU A 167 CD GLU A 167 OE2 0.086 REMARK 500 GLU A 205 CD GLU A 205 OE2 0.072 REMARK 500 GLU B 23 CD GLU B 23 OE2 0.067 REMARK 500 GLU B 53 CD GLU B 53 OE2 0.071 REMARK 500 GLU B 77 CD GLU B 77 OE2 0.083 REMARK 500 GLU B 104 CD GLU B 104 OE2 0.075 REMARK 500 GLU B 133 CD GLU B 133 OE2 0.071 REMARK 500 GLU B 185 CD GLU B 185 OE1 0.078 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 111 CB - CG - OD1 ANGL. DEV. = 6.9 DEGREES REMARK 500 ASP A 111 CB - CG - OD2 ANGL. DEV. = -6.4 DEGREES REMARK 500 ARG A 134 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 ARG A 134 NE - CZ - NH2 ANGL. DEV. = -4.7 DEGREES REMARK 500 ARG A 138 NE - CZ - NH1 ANGL. DEV. = -3.9 DEGREES REMARK 500 ASP A 158 CB - CG - OD2 ANGL. DEV. = -7.6 DEGREES REMARK 500 ASP A 201 CB - CG - OD1 ANGL. DEV. = 6.3 DEGREES REMARK 500 ASP A 201 CB - CG - OD2 ANGL. DEV. = -6.0 DEGREES REMARK 500 ARG A 207 CD - NE - CZ ANGL. DEV. = 10.1 DEGREES REMARK 500 ARG A 207 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 ASP A 227 CB - CG - OD2 ANGL. DEV. = -6.6 DEGREES REMARK 500 ASP A 244 CB - CG - OD1 ANGL. DEV. = -7.5 DEGREES REMARK 500 ASP A 244 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 ASP B 26 CB - CG - OD1 ANGL. DEV. = 6.7 DEGREES REMARK 500 ASP B 26 CB - CG - OD2 ANGL. DEV. = -6.9 DEGREES REMARK 500 TYR B 101 CB - CG - CD1 ANGL. DEV. = 4.5 DEGREES REMARK 500 ASP B 111 CB - CG - OD1 ANGL. DEV. = 6.0 DEGREES REMARK 500 ASP B 111 CB - CG - OD2 ANGL. DEV. = -6.3 DEGREES REMARK 500 ASP B 201 CB - CG - OD1 ANGL. DEV. = 5.6 DEGREES REMARK 500 ASP B 201 CB - CG - OD2 ANGL. DEV. = -5.6 DEGREES REMARK 500 ASP B 227 CB - CG - OD2 ANGL. DEV. = -6.2 DEGREES REMARK 500 ASP B 244 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 13 -147.19 59.73 REMARK 500 CYS A 14 68.69 -101.31 REMARK 500 ASN A 66 164.78 175.37 REMARK 500 LYS B 13 -146.06 53.65 REMARK 500 ALA B 67 163.39 178.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG A 207 0.07 SIDE_CHAIN REMARK 500 REMARK 500 REMARK: NULL

REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEETS PRESENTED AS *A* AND *B* ON SHEET RECORDS BELOW REMARK 700 ARE ACTUALLY EIGHT-STRANDED BETA-BARRELS. THESE ARE REMARK 700 REPRESENTED BY NINE-STRANDED SHEETS IN WHICH THE FIRST AND REMARK 700 LAST STRANDS ARE IDENTICAL.

REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2PG B 300

DBREF 4TIM A 1 250 UNP P04789 TPIS_TRYBB 1 250 DBREF 4TIM B 1 250 UNP P04789 TPIS_TRYBB 1 250

SEQRES 1 A 250 MET SER LYS PRO GLN PRO ILE ALA ALA ALA ASN TRP LYS SEQRES 2 A 250 CYS ASN GLY SER GLN GLN SER LEU SER GLU LEU ILE ASP SEQRES 3 A 250 LEU PHE ASN SER THR SER ILE ASN HIS ASP VAL GLN CYS SEQRES 4 A 250 VAL VAL ALA SER THR PHE VAL HIS LEU ALA MET THR LYS SEQRES 5 A 250 GLU ARG LEU SER HIS PRO LYS PHE VAL ILE ALA ALA GLN SEQRES 6 A 250 ASN ALA ILE ALA LYS SER GLY ALA PHE THR GLY GLU VAL SEQRES 7 A 250 SER LEU PRO ILE LEU LYS ASP PHE GLY VAL ASN TRP ILE SEQRES 8 A 250 VAL LEU GLY HIS SER GLU ARG ARG ALA TYR TYR GLY GLU SEQRES 9 A 250 THR ASN GLU ILE VAL ALA ASP LYS VAL ALA ALA ALA VAL SEQRES 10 A 250 ALA SER GLY PHE MET VAL ILE ALA CYS ILE GLY GLU THR SEQRES 11 A 250 LEU GLN GLU ARG GLU SER GLY ARG THR ALA VAL VAL VAL SEQRES 12 A 250 LEU THR GLN ILE ALA ALA ILE ALA LYS LYS LEU LYS LYS SEQRES 13 A 250 ALA ASP TRP ALA LYS VAL VAL ILE ALA TYR GLU PRO VAL SEQRES 14 A 250 TRP ALA ILE GLY THR GLY LYS VAL ALA THR PRO GLN GLN SEQRES 15 A 250 ALA GLN GLU ALA HIS ALA LEU ILE ARG SER TRP VAL SER SEQRES 16 A 250 SER LYS ILE GLY ALA ASP VAL ALA GLY GLU LEU ARG ILE SEQRES 17 A 250 LEU TYR GLY GLY SER VAL ASN GLY LYS ASN ALA ARG THR SEQRES 18 A 250 LEU TYR GLN GLN ARG ASP VAL ASN GLY PHE LEU VAL GLY SEQRES 19 A 250 GLY ALA SER LEU LYS PRO GLU PHE VAL ASP ILE ILE LYS SEQRES 20 A 250 ALA THR GLN SEQRES 1 B 250 MET SER LYS PRO GLN PRO ILE ALA ALA ALA ASN TRP LYS SEQRES 2 B 250 CYS ASN GLY SER GLN GLN SER LEU SER GLU LEU ILE ASP SEQRES 3 B 250 LEU PHE ASN SER THR SER ILE ASN HIS ASP VAL GLN CYS SEQRES 4 B 250 VAL VAL ALA SER THR PHE VAL HIS LEU ALA MET THR LYS SEQRES 5 B 250 GLU ARG LEU SER HIS PRO LYS PHE VAL ILE ALA ALA GLN SEQRES 6 B 250 ASN ALA ILE ALA LYS SER GLY ALA PHE THR GLY GLU VAL SEQRES 7 B 250 SER LEU PRO ILE LEU LYS ASP PHE GLY VAL ASN TRP ILE SEQRES 8 B 250 VAL LEU GLY HIS SER GLU ARG ARG ALA TYR TYR GLY GLU SEQRES 9 B 250 THR ASN GLU ILE VAL ALA ASP LYS VAL ALA ALA ALA VAL SEQRES 10 B 250 ALA SER GLY PHE MET VAL ILE ALA CYS ILE GLY GLU THR SEQRES 11 B 250 LEU GLN GLU ARG GLU SER GLY ARG THR ALA VAL VAL VAL SEQRES 12 B 250 LEU THR GLN ILE ALA ALA ILE ALA LYS LYS LEU LYS LYS SEQRES 13 B 250 ALA ASP TRP ALA LYS VAL VAL ILE ALA TYR GLU PRO VAL SEQRES 14 B 250 TRP ALA ILE GLY THR GLY LYS VAL ALA THR PRO GLN GLN SEQRES 15 B 250 ALA GLN GLU ALA HIS ALA LEU ILE ARG SER TRP VAL SER SEQRES 16 B 250 SER LYS ILE GLY ALA ASP VAL ALA GLY GLU LEU ARG ILE SEQRES 17 B 250 LEU TYR GLY GLY SER VAL ASN GLY LYS ASN ALA ARG THR SEQRES 18 B 250 LEU TYR GLN GLN ARG ASP VAL ASN GLY PHE LEU VAL GLY SEQRES 19 B 250 GLY ALA SER LEU LYS PRO GLU PHE VAL ASP ILE ILE LYS SEQRES 20 B 250 ALA THR GLN

HET 2PG B 300 11

HETNAM 2PG 2-PHOSPHOGLYCERIC ACID

FORMUL 3 2PG C3 H7 O7 P FORMUL 4 HOH *130(H2 O)

HELIX 1 1A GLN A 18 SER A 30 1 13 HELIX 2 2A LEU A 48 ARG A 54 1 7 HELIX 3 3A LEU A 80 ASP A 85 1 6 HELIX 4 4FA SER A 96 TYR A 101 1 6 HELIX 5 4A ASN A 106 ALA A 118 1 13 HELIX 6 5FA LEU A 131 GLU A 135 1 5 HELIX 7 5A THR A 139 LYS A 152 1 14 HELIX 8 6BA LYS A 156 LYS A 161 5 6 HELIX 9 6A PRO A 180 LYS A 197 1 18 HELIX 10 7BA ALA A 200 GLU A 205 1 6 HELIX 11 7A GLY A 216 TYR A 223 1 8 HELIX 12 8FA GLY A 235 LEU A 238 5 4 HELIX 13 8A PHE A 242 LYS A 247 1 6 HELIX 14 1B GLN B 18 ASN B 29 1 12 HELIX 15 2B LEU B 48 ARG B 54 1 7 HELIX 16 3B LEU B 80 ASP B 85 1 6 HELIX 17 4FB SER B 96 TYR B 101 1 6 HELIX 18 4B ASN B 106 ALA B 118 1 13 HELIX 19 5FB LEU B 131 GLU B 135 1 5 HELIX 20 5B THR B 139 ALA B 151 1 13 HELIX 21 6BB LYS B 156 LYS B 161 5 6 HELIX 22 6B PRO B 180 LYS B 197 1 18 HELIX 23 7BB ALA B 200 GLU B 205 1 6 HELIX 24 7B ALA B 219 GLN B 224 1 6 HELIX 25 8FB GLY B 235 LEU B 238 5 4 HELIX 26 8B PHE B 242 LYS B 247 1 6

SHEET 1 A 9 ILE A 7 ASN A 11 0 SHEET 2 A 9 GLN A 38 SER A 43 1 SHEET 3 A 9 PHE A 60 ALA A 64 1 SHEET 4 A 9 TRP A 90 LEU A 93 1 SHEET 5 A 9 MET A 122 ILE A 127 1 SHEET 6 A 9 VAL A 162 TYR A 166 1 SHEET 7 A 9 ARG A 207 TYR A 210 1 SHEET 8 A 9 GLY A 230 VAL A 233 1 SHEET 9 A 9 ILE A 7 ASN A 11 1 SHEET 1 B 9 ILE B 7 ASN B 11 0 SHEET 2 B 9 GLN B 38 ALA B 42 1 SHEET 3 B 9 PHE B 60 ALA B 64 1 SHEET 4 B 9 TRP B 90 LEU B 93 1 SHEET 5 B 9 MET B 122 ILE B 127 1 SHEET 6 B 9 VAL B 162 TYR B 166 1 SHEET 7 B 9 ILE B 208 TYR B 210 1 SHEET 8 B 9 GLY B 230 VAL B 233 1 SHEET 9 B 9 ILE A 7 ASN A 11 1

SITE 1 AC1 16 ASN B 11 LYS B 13 HIS B 95 GLU B 167 SITE 2 AC1 16 ALA B 171 ILE B 172 GLY B 173 GLY B 211 SITE 3 AC1 16 GLY B 212 SER B 213 LEU B 232 GLY B 234 SITE 4 AC1 16 GLY B 235 HOH B 657 HOH B 663 HOH B 698

CRYST1 112.590 97.290 46.700 90.00 90.00 90.00 P 21 21 21 8

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 0.008882 0.000000 0.000000 0.00000

SCALE2 0.000000 0.010279 0.000000 0.00000

SCALE3 0.000000 0.000000 0.021413 0.00000